Skip to content

Glycemic and Insulinemic Impact of Selected Canadian Beans

Glycemic and Insulinemic Impact of Selected Canadian Beans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02907190
Acronym
MED-beans
Enrollment
18
Registered
2016-09-20
Start date
2016-03-31
Completion date
2016-09-30
Last updated
2016-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Glucose Tolerance

Keywords

pulses, beans, blood glucose, insulin

Brief summary

The objective of this study is to compare the glycemic and insulinemic response elicited by ½ cup servings of 6 beans to those elicited by ½ cup servings of mashed potato, macaroni, rice and corn.

Detailed description

In order for a food to be able to claim a reduced glycemic response, it must be shown that a typical serving of the food elicits a significantly lower blood glucose responses compared to a serving of an appropriate control food. While many studies have examined the GI of beans, few studies have compared the glycemic impact of a typical serving of beans to a typical serving of other starchy foods. Therefore, there are insufficient data to allow for a claim that beans have a low glycemic response. In addition, in order to make a claim of a reduced glycemic response, regulatory agencies also require that the insulinemic response to a food is not disproportionately increased.

Interventions

OTHERBean Type

1/2 cup of freshly boiled beans will be eaten by participants on separate study visits

OTHERStarchy Foods

1/2 cup serving of one of 4 starchy foods will be eaten by participants on different study visit

Sponsors

Glycemic Index Laboratories, Inc
CollaboratorINDUSTRY
Ontario Bean Growers Association
CollaboratorUNKNOWN
Guelph Food Research Centre
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or non-pregnant females, 18-75 years of age, inclusive * Body mass index (BMI) \< 40 kg/m² * Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial and to refrain from smoking for 12hr prior to each visit. * Normal fasting serum glucose (\<7.0mmol/L capillary corresponding to whole blood glucose \<6.3mmol/L). * Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.

Exclusion criteria

* Failure to meet any one of the inclusion criteria * Known history of AIDS, hepatitis, diabetes or a heart condition * Subjects using medications or with any condition which might, in the opinion of Dr. Wolever, the Medical Director of GI Labs, either: 1) make participation dangerous to the subject or to others, or 2) affect the results. * Major trauma or surgical event within 3 months of screening. * Unwillingness or inability to comply with the experimental procedures and to follow GI Labs safety guidelines. * Known intolerance, sensitivity or allergy to any ingredients in the study products.

Design outcomes

Primary

MeasureTime frameDescription
Glycemic Response120 minutespost prandial blood glucose response

Secondary

MeasureTime frameDescription
Insulin Response120 minutespost prandial blood insulin response

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026